©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 110453
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.110453
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.110453
Figure 1 Region-specific modeling using gastric organoids.
TFF2: Trefoil factor 2; Lgr5: Leucine-rich-repeat-containing G-protein-coupled receptor 5; SoX2: SRY-box transcription factor 2; EGF: Epidermal growth factor.
- Citation: Liu C, Wu CH, Jia YB, Qiu JX, Li XY, Ling JH. Gastric organoids: A promising model for studying “inflammation-cancer” transition in atrophic gastritis. World J Clin Oncol 2025; 16(11): 110453
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/110453.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.110453